Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
- 11 December 2009
- Vol. 28 (2) , 329-337
- https://doi.org/10.1016/j.vaccine.2009.10.045
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysisPublished by Elsevier ,2009
- Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ productionHuman Immunology, 2009
- The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and EliminationPLoS Neglected Tropical Diseases, 2008
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvantCellular and Molecular Life Sciences, 2008
- Control of Neglected Tropical DiseasesNew England Journal of Medicine, 2007
- Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing CellsJournal of Virology, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Leishmaniavaccines: progress and problemsParasitology, 2006
- Field Trial of a Vaccine against New World Cutaneous Leishmaniasis in an At‐Risk Child Population: How Long Does Protection Last?The Journal of Infectious Diseases, 2003
- Prophylactic Immunization against Experimental Leishmania donovani Infection by Use of a Purified Protein VaccineThe Journal of Infectious Diseases, 1990